Cargando...
Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
OBJECTIVE: To compare 2‐year effectiveness and discontinuation of natalizumab (NTZ) versus fingolimod (FTY) and dimethyl fumarate (DMF) in the treatment of multiple sclerosis (MS). METHODS: Patients prescribed NTZ, FTY, or DMF at the Rocky Mountain MS Center at University of Colorado were identified...
Gardado en:
| Publicado en: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389745/ https://ncbi.nlm.nih.gov/pubmed/30847358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.700 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|